Manufacturer copay assistance · Syfovre (J2781) · Apellis Pharmaceuticals
$0 · Maximum benefit $25,000/year · Covers drug and administration costs
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
No foundation fund in our catalog currently matches Syfovre — check the full fund board.
Yes — ApellisAssist Co-Pay Program from Apellis Pharmaceuticals. $0. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
$0 Maximum benefit: $25,000/year. Covers drug and administration costs
Accepted insurance: commercial. Not eligible: medicare, medicaid, va, government, tricare. Income limit: No income requirement.